Official 2024 U.S. DOL Form 5500 summary for Seattle Institute For Biomedical And Clinical Research (Seattle Institute For Biomedical And Clinical Research 403(b) Dc Plan · EIN 91-1452438 · PN 001): $20.61M net assets, 115 active participants, and $27.21 per $10,000 (27.21 bps).
| Plan Sponsor | Seattle Institute For Biomedical And Clinical Research |
|---|---|
| Filing Identifier | Seattle Institute For Biomedical And Clinical Research 403(b) Dc Plan · EIN 91-1452438 · PN 001 |
| Plan Category & State | 403(b) Tax-Exempt DC (WA) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $20.61M |
| Active Participants | 115 |
| Direct Admin Fee Rate | $27.21 per $10,000 (27.21 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Usi Advisors, INC. |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI